Full Press Release Details
LOS ANGELES--(BUSINESS WIRE)--Puma biotechnology reported that it granted inducement awards in October 2026, as required under
Nasdaq Listing Rule 5635(c)(4).
PBYI Neutral Sentiment
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Key Takeaway: Puma Biotechnology granted inducement awards in October 2026. This action complies with Nasdaq Listing Rule 5635(c)(4). The company reported this standard regulatory filing to maintain its listing status. No financial figures or specific award details were disclosed in the announcement.
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+56%
120-day peak, hindsight
Typical move
1.7%
average across 3 past catalysts
Lead asset
Alisertib
Phase 2 · Small Cell Lung Cancer
Frequently Asked Questions
What are inducement awards?
Inducement awards are stock options or equity grants given to attract talent.
Why did Puma grant inducement awards?
Puma granted inducement awards to comply with Nasdaq Listing Rule 5635(c)(4).
When were the inducement awards granted?
The inducement awards were granted in October 2026.
What is Nasdaq Listing Rule 5635(c)(4)?
This rule requires companies to obtain shareholder approval for certain equity awards.